Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Biovice Systems ApS
APS
Bankrupt
CVR 41034548
Jernbanegade 14B, 2. th
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2019
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2021
DKK -73K
-84% vs 2020
EBITDA margin
1157.3%
+20% vs 2020
Equity ratio
-936.3%
Financial strength
Net profit 2021
DKK -888K
+16% vs 2020
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2020
-1M
0%
2021
Key figures
Annual report 2021
Revenue
DKK -73K
-84%
EBITDA
DKK -840K
+20%
Net profit
DKK -888K
+16%
Total assets
DKK 202K
-20%
Equity
DKK -1,9M
-87%
Employees
1
—
Company information
Legal name
Biovice Systems ApS
CVR number
41034548
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
19. december 2019
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Contact
Address
Jernbanegade 14B, 2. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in Hjørring
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2020
-1M
2021
Income statement
DKK thousands
Item
2020
2021
Revenue
-459
-73
Staff expenses
-546
-767
EBITDA
-1.046
-840
Depreciation & amort.
-4
-7
EBIT
-1.050
-847
Net financials
-2
-41
Profit before tax
-1.052
-888
Tax
-0
-0
Net profit
-1.052
-888
Balance sheet
DKK thousands
Item
2020
2021
Total assets
251
202
Equity
-1.012
-1.890
Long-term debt
0
0
Short-term debt
1.264
2.092
Total debt
1.264
2.092
Financial ratios
5-year trend
EBITDA margin
-83955000.0%
This company
15.8%
Market median
-531360859% vs market
2020
2021
Equity ratio
-936.3%
This company
38.2%
Market median
-2551% vs market
2020
2021
Return on equity
-88761000.0%
This company
18.4%
Market median
-482396839% vs market
2020
2021
Net profit margin
-88761000.0%
This company
8.1%
Market median
-1095814915% vs market
2020
2021
Asset turnover
-0.36×
This company
1.12×
Market median
-132% vs market
2020
2021
Debt / equity
1.11×
This company
0.62×
Market median
-79% vs market
2020
2021
Annual reports & filings
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-12-19 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
GT
Gulliver Thomsen Christensen
Management
Management
2022
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Allan Grutt Hansen
Individual
5.0%
5.0%
2021
Tom Højlund Pedersen
Individual
5.0%
5.0%
2021
Lars Thomsen
Individual
66.7%
66.7%
2021
Simon Leicht Simonsen
Individual
100.0%
100.0%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Biovice Systems ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Gulliver Thomsen Christensen
Management
0 companies